1. Home
  2. CDZI vs DRUG Comparison

CDZI vs DRUG Comparison

Compare CDZI & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$5.79

Market Cap

444.6M

Sector

Utilities

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$84.00

Market Cap

364.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
DRUG
Founded
1983
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Pharmaceuticals and Biotechnology
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
444.6M
364.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDZI
DRUG
Price
$5.79
$84.00
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$89.00
AVG Volume (30 Days)
602.2K
178.8K
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,979,000.00
N/A
Revenue This Year
$58.18
N/A
Revenue Next Year
$32.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
188.33
N/A
52 Week Low
$2.13
$23.18
52 Week High
$6.49
$97.75

Technical Indicators

Market Signals
Indicator
CDZI
DRUG
Relative Strength Index (RSI) 56.38 57.71
Support Level $5.36 $75.11
Resistance Level $5.95 $89.71
Average True Range (ATR) 0.29 7.19
MACD 0.00 -1.33
Stochastic Oscillator 80.04 39.27

Price Performance

Historical Comparison
CDZI
DRUG

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: